Fumie Shimada, Yusuke Yoshimatsu, Tomohisa Sujino, Tomohiro Fukuda, Yasuhiro Aoki, Yukie Hayashi, Anna Tojo, Takaaki Kawaguchi, Hiroki Kiyohara, Shinya Sugimoto, Kosaku Nanki, Yohei Mikami, Kentaro Miyamoto, Kaoru Takabayashi, Naoki Hosoe, Motohiko Kato, Haruhiko Ogata, Makoto Naganuma, Takanori Kanai
Indigo naturalis is an effective treatment for ulcerative colitis. However, long-term use of indigo naturalis causes adverse events, such as pulmonary hypertension. The natural history of patients with ulcerative colitis who discontinued indigo naturalis after induction therapy is unknown. Moreover, the clinical features of patients who relapsed within 52 weeks after the discontinuation of indigo naturalis are unclear. This study aimed to assess the clinical outcomes of patients with ulcerative colitis after discontinuation of indigo naturalis and to identify potential markers responsible for relapse...
March 9, 2024: Scientific Reports